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a b s t r a c t
Background: Documentation of influenza vaccination, including the specific product received, is critical to
estimate annual vaccine effectiveness (VE).
Methods: We assessed performance of the Michigan Care Improvement Registry (MCIR) in defining influenza vaccination status relative to documentation by provider records or self-report among subjects
enrolled in a study of influenza VE from 2011 through 2019.
Results: The specificity and positive predictive value of MCIR were high; however, >10% of vaccinations
were identified only by other sources each season. The proportion of records captured by MCIR increased
from a low of 67% in 2013–2014 to a high of 89% in 2018–2019, largely driven by increased capture of
vaccination among adults.
Conclusions: State vaccine registries, such as MCIR, are important tools for documenting influenza vaccination, including the specific product received. However, incomplete capture suggests that documentation from other sources and self-report should be used in combination with registries to reduce
misclassification.
Ó 2021 Elsevier Ltd. All rights reserved.

Rapid evolution of influenza viruses leads to loss of population
immunity resulting in annual epidemics [1]. Because of this influenza virus antigenic drift, the strain composition of influenza vaccines is evaluated twice annually (once for the Northern
Hemisphere, and once for the Southern) often resulting in updates.
Vaccine effectiveness can vary widely from year to year, largely
related to the match between the vaccine and circulating virus
strains [2]. To monitor this variable effectiveness, many countries
carry out annual observational studies, typically using the case
test-negative design. These studies depend on accurate determination of influenza vaccination status for unbiased estimation of
influenza vaccine effectiveness. Misclassified vaccination status
could unpredictably bias vaccine effectiveness estimates depending on whether the misclassification is also associated with risk
of influenza infection.

Abbreviations: CDC, Centers for Disease Control and Prevention; CI, confidence
interval; MCIR, Michigan Care Improvement Registry; US, United States; VE, vaccine
effectiveness.
⇑ Corresponding author at: University of Michigan, School of Public Health, 1415
Washington Heights, Ann Arbor, MI 48109, United States.
E-mail address: jpetrie@umich.edu (J.G. Petrie).

In most populations, influenza vaccination is not mandatory
and the choice of whether to be vaccinated, when to be vaccinated,
and which product to receive is determined by individuals and the
options available to them. As a result, methods for determining
influenza vaccination status vary across studies depending on local
populations and practices. Self-report of vaccination has previously
been shown to have relatively high sensitivity and specificity relative to comprehensive vaccination registries [3–7]. However, documentation of vaccination is typically required to ascertain
details about the specific vaccine product. A variety of influenza
vaccine products are now licensed for use in the United States with
important differences in the type of vaccine (inactivated vs liveattenuated), number of strains included (trivalent vs quadrivalent),
method of production (egg grown, cell-culture grown, recombinant), dose (high dose vs standard dose), and inclusion of an adjuvant [8]. Comparison of the effectiveness of these various products
requires complete and accurate documentation of the vaccines that
individuals receive. Unfortunately, the performance of sources of
vaccination documentation can vary and may not outperform
self-report [9].
The immunization registry for the state of Michigan (Michigan
Care Improvement Registry [MCIR]) was created in 1998 with

https://doi.org/10.1016/j.vaccine.2021.07.090
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The performance of MCIR in documenting influenza vaccination
was assessed relative to vaccination documented by health system
records, outside provider records, or self-report. Percent agreement, Cohen’s kappa, sensitivity, specificity, positive predictive
value, and negative predictive values were calculated for each
study year. The kappa statistic was interpreted as: 0–0.20 no
agreement, 0.21–0.39, minimal; 0.40–0.59, weak; 0.60–0.79 moderate; 0.80–0.90 strong; and >0.90 almost perfect [11]. These
statistics were calculated overall, for adults 20 years, and for children <20 years for whom MCIR reporting is mandated.
Among subjects defined as vaccinated by combined provider
records and self-report, the proportion documented by MCIR was
compared by age group, sex, race/ethnicity, and vaccine provider
type for each study year and trends over time assessed.
All statistical analysis was performed using SAS (version 9.4).

mandated reporting of all vaccinations administered in the state to
persons younger than 20 years of age [10]. In 2006, the registry
was expanded to accommodate vaccination records for people of
all ages, although only the reporting of vaccinations for children
remained mandatory. We compared the performance of MCIR in
defining influenza vaccination status relative to self-report and
vaccine provider records.
1. Methods
1.1. Study population
This study included data collected as part of the US Flu Vaccine
Effectiveness Network study at the Michigan participating site during eight consecutive influenza seasons from 2011–2012 through
2018–2019. Participants were identified when they presented for
treatment of acute respiratory illness to Michigan Medicine or
Henry Ford Health System outpatient clinics throughout Southeast
Michigan. Patients 6 months of age were eligible for enrollment if
they were seeking care for an acute respiratory illness with a cough
of 7 or fewer days duration. Participant characteristics, including
age, sex, race, and Hispanic ethnicity were determined by selfreport during an enrollment interview. Informed consent was
obtained from participants over age 18 or the parent/guardian of
participants under age 18; participants between ages 7–17 additionally provided verbal assent for participation. The study was
reviewed and approved by the IRBs at the University of Michigan
Medical School and Henry Ford Health System.

2. Results
In total, 11,503 participants were included in this analysis;
annual enrollment varied from a low of 905 in 2013–2014 to a high
of 1,945 in 2018–2019. Females consistently represented a slight
majority of enrolled participants in each season. The distributions
of age, race, and health system of enrollment varied from year to
year (Table 1). Influenza vaccination coverage defined by any
source (MCIR, health system or provider records, or self-report)
increased over time from 45% in 2011–2012 to 66% in 2018–2019.
Overall, the performance of MCIR in documenting influenza
vaccination improved over time relative to combined provider
records and self-report (Table 2). In the first four years of the study,
there was moderate agreement between MCIR and combined provider records and self-report (Kappa range: 0.63–0.73). There was
strong agreement in the last four years of the study (Kappa range:
0.83–0.86). In all years, the specificity and positive predictive value
of MCIR records were very high reflecting that few vaccination
records were identified by MCIR but not other sources. In contrast,
the sensitivity and negative predictive value of MCIR records were
lower reflecting that more than 10% of vaccinations identified by
other sources were not captured by MCIR in each season. However,
these measures did improve over time. The proportion of records
not captured by MCIR decreased from a high of 33% in 2013–
2014 to a low of 11% in 2018–2019. Over the same years, the sensitivity improved from 67% to 89% and the negative predictive
value improved from 69% to 82%.
The performance of MCIR in documenting influenza vaccination
defined by combined provider records and self-report varied by
age and type of vaccine provider. For children 19 years and
younger, for whom reporting is mandated, MCIR captured over
90% of vaccinations in most years (Fig. 1). MCIR capture for adults
was much lower in the first half of the study period, but
approached levels observed for children by the end of the study
period. MCIR capture for adults 20–64 years increased from 51%
in 2010–2011 to 85% in 2018–2019, and capture for older adults
increased from 33% in 2010–2011 to 93% in 2018–2019. The distribution of vaccine provider types remained relatively stable over
time (Fig. 2A), with vaccination in the enrolling health system representing the majority of vaccines received each year (range 75–
84%). MCIR consistently captured most (range 90–97%) of the vaccinations given in Health System A each year (Fig. 2B). Documentation in MCIR of vaccinations given in Health System B and from
pharmacies increased over time with MCIR capturing over 90% of
vaccination from these sources in 2018–2019. Relatively few vaccinations were received from sources outside the enrolling health
systems, and as a result the percent of these vaccinations captured
by MCIR was more variable from year to year. Nevertheless, some
trends were observed. Capture of vaccinations received at work or

1.2. Vaccination status
Participants, or their parent/guardian, reported their influenza
vaccination status at enrollment. If vaccinated, they were also
asked to report the date and location of vaccine receipt. Participants were defined vaccinated by self-report if they were able to
report the approximate date and location of vaccine receipt; participants were defined as unvaccinated if they reported that they had
not received influenza vaccination in the current season; all other
participants were considered to have unknown self-reported influenza vaccination status. Vaccination records were sought from
each health system’s electronic medical records and MCIR for all
participants regardless of self-reported vaccination status. Documentation of vaccine receipt for those who reported vaccination
from a provider other than the enrolling health system, such as
out of system clinics, pharmacies, work or other community providers, was also requested from the specified provider.
Type of vaccine provider was based on self-reported vaccine
location and categorized as health system of enrollment, out of system clinic, pharmacy, or work/community provider. Participants
who reported that they were unvaccinated, but had a record of vaccination from the health system of enrollment were considered to
have been vaccinated in that health system. Participants who
reported that they were vaccinated in the health system of enrollment, but had no record of vaccination in that system’s records
were considered to have been vaccinated at an unknown provider
type.
1.3. Statistical analysis
Annual study populations were characterized by age group (<5,
5–19, 20–64, and 65 years), sex, race/ethnicity, health system of
enrollment, and influenza vaccination determined by MCIR, health
system, outside provider records, or self-report. The health system
of enrollment is de-identified in the results and reported as Health
System A or B.
5342
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Table 1
Demographic characteristics of study participants by study year.

Age
<5 years
5–19 years
20–64 years
65 years
Sex
Female
Male
Race/Ethnicity
Non-Hispanic White
Non-Hispanic Black
Asian
Hispanic
Other/Multiracial/Unknown
Health System of Enrollment
A
B
Influenza Vaccinationa
Yes
No
Total
a

2011–2012
No. (%)

2012–2013
No. (%)

2013–2014
No. (%)

2014–2015
No. (%)

2015–2016
No. (%)

2016–2017
No. (%)

2017–2018
No. (%)

2018–2019
No. (%)

368 (25.8)
427 (30)
549 (38.5)
81 (5.7)

309 (21.7)
456 (32)
569 (39.9)
92 (6.5)

160 (17.7)
180 (19.9)
468 (51.7)
97 (10.7)

311
403
697
176

248
404
571
105

269
414
569
113

286
402
671
163

293
452
933
267

816 (57.3)
609 (42.7)

799 (56)
627 (44)

547 (60.4)
358 (39.6)

927 (58.4)
660 (41.6)

757 (57)
571 (43)

788 (57.7)
577 (42.3)

880 (57.8)
642 (42.2)

1209 (62.2)
736 (37.8)

791 (55.5)
350 (24.6)
68 (4.8)
86 (6)
130 (9.1)

801 (56.2)
326 (22.9)
69 (4.8)
86 (6)
144 (10.1)

552 (61)
190 (21)
44 (4.9)
54 (6)
65 (7.2)

1027 (64.7)
270 (17)
83 (5.2)
77 (4.9)
130 (8.2)

894 (67.3)
192 (14.5)
57 (4.3)
58 (4.4)
127 (9.6)

932 (68.3)
180 (13.2)
70 (5.1)
89 (6.5)
94 (6.9)

987 (64.9)
205 (13.5)
121 (8)
84 (5.5)
125 (8.2)

1272 (65.4)
381 (19.6)
110 (5.7)
97 (5)
85 (4.4)

619 (43.4)
806 (56.6)

820 (57.5)
606 (42.5)

506 (55.9)
399 (44.1)

1045 (65.9)
542 (34.2)

947 (71.3)
381 (28.7)

958 (70.2)
407 (29.8)

996 (65.4)
526 (34.6)

1421 (73.1)
524 (26.9)

646 (45.3)
779 (54.7)
1425

746 (52.3)
680 (47.7)
1426

514 (56.8)
391 (43.2)
905

980 (61.8)
607 (38.3)
1587

796 (59.9)
532 (40.1)
1328

775 (56.8)
590 (43.2)
1365

918 (60.3)
604 (39.7)
1522

1285 (66.1)
660 (33.9)
1945

(19.6)
(25.4)
(43.9)
(11.1)

(18.7)
(30.4)
(43)
(7.9)

(19.7)
(30.3)
(41.7)
(8.3)

(18.8)
(26.4)
(44.1)
(10.7)

(15.1)
(23.2)
(48)
(13.7)

Defined by any source (MCIR, health system or provider records, or self-report).

Table 2
Comparison of vaccination status defined by Michigan Care Improvement Registry (MCIR) relative to vaccination documented by health system records, outside provider records,
or self-report.

2011–2012
MCIR vaccinated
MCIR unvaccinated
2012–2013
MCIR vaccinated
MCIR unvaccinated
2013–2014
MCIR vaccinated
MCIR unvaccinated
2014–2015
MCIR vaccinated
MCIR unvaccinated
2015–2016
MCIR vaccinated
MCIR unvaccinated
2016–2017
MCIR vaccinated
MCIR unvaccinated
2017–2018
MCIR vaccinated
MCIR unvaccinated
2018–2019
MCIR vaccinated
MCIR unvaccinated

Vaccinateda

Unvaccinateda

Percent Agreement

Kappa

Sensitivity
(95% CI)

Specificity
(95% CI)

PPV
(95% CI)

NPV
(95% CI)

458
171

7
684

86.5

0.73

72.8 (69.2, 76.3)

99.0 (97.9, 99.6)

98.5 (96.9, 99.4)

80.0 (77.2, 82.6)

537
202

2
645

85.3

0.71

72.7 (69.3, 75.9)

99.7 (98.9, 100)

99.6 (98.7, 100)

76.2 (73.1, 79.0)

342
170

1
375

80.7

0.63

66.8 (62.5, 70.9)

99.7 (98.5, 100)

99.7 (98.4, 100)

68.8 (64.7, 72.7)

762
213

0
575

86.3

0.73

78.2 (75.4, 80.7)

100 (99.4, 100)

100 (99.5, 100)

73.0 (69.7, 76.0)

685
109

0
511

91.6

0.83

86.3 (83.7, 88.6)

100 (99.3, 100)

100 (99.5, 100)

82.4 (79.2, 85.3)

675
90

1
554

93.1

0.86

88.2 (85.7, 90.4)

99.8 (99.0, 100)

99.9 (99.2, 100)

86.0 (83.1, 88.6)

800
107

1
565

92.7

0.85

88.2 (85.9, 90.2)

99.8 (99.0, 100)

99.9 (99.3, 100)

84.1 (81.1, 86.8)

1133
135

5
620

92.6

0.84

89.4 (87.5, 91.0)

99.2 (98.1, 99.7)

99.6 (99.0, 99.9)

82.1 (79.2, 84.8)

Abbreviations: 95% CI, 95% confidence interval; PPV, positive predictive value; NPV, negative predictive value.
a
Defined by combined health system records, outside provider records, or self-report.

whom reporting is mandated. Overall, the performance of the registry improved over time. This improvement was largely driven by
increased capture of adult vaccinations which approached that of
children by 2018–2019 even though reporting was not required
for adults during the entire study period. However, the sensitivity
and negative predictive value of MCIR were <90% even in the most
recent study year. This suggests that other sources including provider records and self-report ideally should continue to be used in
combination with vaccine registries to reduce misclassification of
vaccination status.
The mechanism of vaccine provider reporting seems to be an
important factor in whether vaccines are captured in the registry.

other community sites increased over time, but peaking at only
61% in 2017–2018. In each year, there was moderate capture of
vaccination from out of system clinics, and low capture of vaccinations from unknown locations with no consistent pattern over
time. Capture of vaccinations by MCIR did not vary substantially
by sex or race/ethnicity (Supplementary Fig. 1).

3. Discussion
During our study period MCIR consistently captured 90% of
influenza vaccinations received by children <20 years of age for
5343
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Percent MCIR Capture

100%

<5 years
5-19 years

80%

20-64 years
≥65 years

60%
40%
20%
0%

1

Defined by combined health system records, outside provider records, or self-report.

Fig. 1. Percent of influenza vaccinations (Defined by combined health system records, outside provider records, or self-report.) captured by the Michigan Care Improvement
Registry (MCIR) by age: 2011–2019.

Percent of Vaccinations

100%

Unknown

80%

Work /
Community

60%

Pharmacy

40%

Other Clinic

20%

Enrollment
Health System

Percent MCIR Capture

0%

100%

Health System A

80%

Health System B

60%

Other Clinic

40%

Pharmacy

20%

Work /
Community
Unknown

0%

Fig. 2. (A) Proportion of influenza vaccinations given by provider type, and (B) percent of influenza vaccinations captured by the Michigan Care Improvement Registry (MCIR)
by provider type: 2011–2019.

sistently improved over the study period, but reporting remained
lower than for the enrolling health systems and pharmacies. This
likely reflects heterogeneity in the providers of vaccines at these
locations. For example, some commercial pharmacies provide
onsite vaccination services to large employers and these records
may be reported through the pharmacy’s usual mechanisms.
Despite overall increases, reporting from clinics outside the
enrolling health systems, work or community providers, and other

Health System B transitioned to a new electronic medical record
software in the 2013–2014 season that facilitated automatic
reporting to MCIR. After a decrease during this transition year,
MCIR reporting from Health System B dramatically increased. This
improved reporting from Health System B, along with continuous
improvement in reporting from commercial pharmacies during
the study period, drove the majority of improvement in reporting
for adults. Reporting from work or community providers also con5344
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providers remains relatively low. These providers typically
accounted for around 10% of the vaccines received in our study
population, but likely account for a higher percentage vaccines
provided nationally. According to the Centers for Disease Control
and Prevention, 42.3% of adults receive their influenza vaccine at
a non-medical setting [12]. This highlights the ongoing need to
seek records from providers who do not routinely report to
registries.
We studied the performance of MCIR in capturing records of
influenza vaccination for participants enrolled from ambulatory
clinics in 2 health systems. The performance of MCIR among these
patients may not be generalizable to individuals who receive care
from other health systems or those who do not have a primary care
provider. In addition, while all 50 states have registries based on
the Immunization Information System [13], the performance of
vaccine registries is likely to vary by local reporting, legislation,
and other factors. We compared influenza vaccination records
from MCIR to vaccination defined by combined provider records
and self-report. While previous studies have demonstrated selfreport to be reliable, some level of misclassification in our definition of vaccination status is likely. As a result, we might be underestimating the performance of MCIR.
Assessment of the relative effectiveness of the various currently
available influenza vaccine products is critical to informing their
use in different groups to maximize population-level benefits. In
addition, the next generation of influenza vaccines, developed in
accordance with the National Institute of Allergy and Infectious
Diseases strategic plan, will need to be evaluated in real world situations once they are licensed [14]. The three currently authorized
SARS-CoV-2 vaccines and those still in development will need continued study following licensure to evaluate long-term protection
and safety [15–18]. Vaccination registries that accurately document the exact product that is received by an individual are critical
to these evaluations. The State of Michigan’s vaccine registry,
MCIR, is a valuable resource for this information, but its capture
could be improved by targeting private medical practices and organizations that provide vaccination in workplaces and other community settings for improved reporting. Along with other
registries nationally, MCIR will useful in providing necessary information on vaccines deployed not only for children but for broad
age groups.

Disclaimer
The content of this publication does not necessarily reflect the
official views or policies of the Department of Health and Human
Services, nor does mention of trade names, commercial products,
or organizations imply endorsement by the U.S. Government.
Appendix A. Supplementary material
Supplementary data to this article can be found online at
https://doi.org/10.1016/j.vaccine.2021.07.090.
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